Cover Image
Market Research Report
Product code 
1071688

Global Omics-Based Clinical Trials Market Size study, by Phase, By Study Design, By Indication (Oncology, Cardiology, Respiratory Diseases, Skin Diseases, CNS Diseases, Immunology, Genetic Diseases, Others ) and Regional Forecasts 2022-2028

Published: | Bizwit Research & Consulting LLP | Delivery time: 2-3 business days

Price

Back to Top
Global Omics-Based Clinical Trials Market Size study, by Phase, By Study Design, By Indication (Oncology, Cardiology, Respiratory Diseases, Skin Diseases, CNS Diseases, Immunology, Genetic Diseases, Others ) and Regional Forecasts 2022-2028
Published: April 22, 2022
Bizwit Research & Consulting LLP
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

Global Omics-Based Clinical Trials Market is valued at approximately USD 24.4 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.4 % over the forecast period 2022-2028. Omics-Based Clinical Trials are used for the clinical analysis of patients related to genomics, metabolomics epigenomics, proteomics etc. The growing incidences of chronic diseases have led to the adoption of Omics-Based Clinical Trials across the forecast period. For Instance: According to the Centers for Disease Control and Prevention in 2021, the number of cases and deaths by chronic diseases is increasing rapidly. The diabetic cases with illness have affected 285 million people which is equivalent to about 6.4 % of the total adult population globally. Increasing investment by pharmaceutical companies pushes the market growth of omics-based clinical trials. Also, with the increasing demand for omics approaches for clinical trials, the adoption & demand for Omics-Based Clinical Trials is likely to increase the market growth during the forecast period. However, higher costs of clinical trials impede the growth of the market over the forecast period of 2022-2028.

The geographical regions considered for the global Omics-Based Clinical Trials market analysis include Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of huge market share due to the increasing cases of chronic disorders, presence of key players and growing investment towards the advancement of healthcare. Whereas, Asia-Pacific is also estimated to attain a maximum growth rate during 2022-2028. Factors such as increasing R&D in clinical trials and increasing government expenditure towards the healthcare sector would create beneficial growth forecasts for the Omics-Based Clinical Trials market across Asia-Pacific region.

Major market players included in this report are:

Parexel International Corporation

Pharmaceutical Product Development (PPD)

Charles River Laboratory

ICON plc

SGS SA

Eli Lilly and Company

Pfizer Inc.

Covance Inc.

Novo Nordisk

Rebus Bio

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Phase:

Phase I

Phase II

Phase III

Phase IV

By Study Design:

Interventional Studies

Observational Studies

Expanded Access Studies

By Indication:

Oncology

Cardiology

Respiratory Diseases

Skin Diseases

CNS Diseases

Immunology

Genetic Diseases (includes the rare diseases)

Others (includes ophthalmic, ear diseases, etc)

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019,2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Omics-Based Clinical Trials Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028(USD Billion)
    • 1.2.1. Omics-Based Clinical Trials Market, by Region, 2020-2028(USD Billion)
    • 1.2.2. Omics-Based Clinical Trials Market, by Phase, 2020-2028(USD Billion)
    • 1.2.3. Omics-Based Clinical Trials Market, by Study Design, 2020-2028(USD Billion)
    • 1.2.4. Omics-Based Clinical Trials Market, by Indication, 2020-2028(USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Omics-Based Clinical Trials Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Omics-Based Clinical Trials Market Dynamics

  • 3.1. Omics-Based Clinical Trials Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing incidences of chronic diseases
      • 3.1.1.2. Increasing investment by pharmaceutical companies
    • 3.1.2. Market Challenges
      • 3.1.2.1. Higher cost of clinical trials
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing demand for omics approaches for clinical trials

Chapter 4. Global Omics-Based Clinical Trials Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2019-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Omics-Based Clinical Trials Market, by Phase

  • 6.1. Market Snapshot
  • 6.2. Global Omics-Based Clinical Trials Market by Phase, Performance - Potential Analysis
  • 6.3. Global Omics-Based Clinical Trials Market Estimates & Forecasts by Phase, 2019-2028 (USD Billion)
  • 6.4. Omics-Based Clinical Trials Market, Sub Segment Analysis
    • 6.4.1. Phase I
    • 6.4.2. Phase II
    • 6.4.3. Phase III
    • 6.4.4. Phase IV

Chapter 7. Global Omics-Based Clinical Trials Market, by Study Design

  • 7.1. Market Snapshot
  • 7.2. Global Omics-Based Clinical Trials Market by Study Design, Performance - Potential Analysis
  • 7.3. Global Omics-Based Clinical Trials Market Estimates & Forecasts by Study Design, 2019-2028 (USD Billion)
  • 7.4. Omics-Based Clinical Trials Market, Sub Segment Analysis
    • 7.4.1. Interventional Studies
    • 7.4.2. Observational Studies
    • 7.4.3. Expanded Access Studies

Chapter 8. Global Omics-Based Clinical Trials Market, by Indication

  • 8.1. Market Snapshot
  • 8.2. Global Omics-Based Clinical Trials Market by Indication, Performance - Potential Analysis
  • 8.3. Global Omics-Based Clinical Trials Market Estimates & Forecasts by Indication, 2019-2028 (USD Billion)
  • 8.4. Omics-Based Clinical Trials Market, Sub Segment Analysis
    • 8.4.1. Oncology
    • 8.4.2. Cardiology
    • 8.4.3. Respiratory Diseases
    • 8.4.4. Skin Diseases
    • 8.4.5. CNS Diseases
    • 8.4.6. Immunology
    • 8.4.7. Genetic Diseases (includes the rare diseases)
    • 8.4.8. Others (includes ophthalmic, ear diseases, etc)

Chapter 9. Global Omics-Based Clinical Trials Market, Regional Analysis

  • 9.1. Omics-Based Clinical Trials Market, Regional Market Snapshot
  • 9.2. North America Omics-Based Clinical Trials Market
    • 9.2.1. U.S. Omics-Based Clinical Trials Market
      • 9.2.1.1. Phase breakdown estimates & forecasts, 2019-2028
      • 9.2.1.2. Study Design breakdown estimates & forecasts, 2019-2028
      • 9.2.1.3. Indication breakdown estimates & forecasts, 2019-2028
    • 9.2.2. Canada Omics-Based Clinical Trials Market
  • 9.3. Europe Omics-Based Clinical Trials Market Snapshot
    • 9.3.1. U.K. Omics-Based Clinical Trials Market
    • 9.3.2. Germany Omics-Based Clinical Trials Market
    • 9.3.3. France Omics-Based Clinical Trials Market
    • 9.3.4. Spain Omics-Based Clinical Trials Market
    • 9.3.5. Italy Omics-Based Clinical Trials Market
    • 9.3.6. Rest of Europe Omics-Based Clinical Trials Market
  • 9.4. Asia-Pacific Omics-Based Clinical Trials Market Snapshot
    • 9.4.1. China Omics-Based Clinical Trials Market
    • 9.4.2. India Omics-Based Clinical Trials Market
    • 9.4.3. Japan Omics-Based Clinical Trials Market
    • 9.4.4. Australia Omics-Based Clinical Trials Market
    • 9.4.5. South Korea Omics-Based Clinical Trials Market
    • 9.4.6. Rest of Asia Pacific Omics-Based Clinical Trials Market
  • 9.5. Latin America Omics-Based Clinical Trials Market Snapshot
    • 9.5.1. Brazil Omics-Based Clinical Trials Market
    • 9.5.2. Mexico Omics-Based Clinical Trials Market
  • 9.6. Rest of The World Omics-Based Clinical Trials Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Parexel International Corporation
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Pharmaceutical Product Development (PPD)
    • 10.2.3. Charles River Laboratory
    • 10.2.4. ICON plc
    • 10.2.5. SGS SA
    • 10.2.6. Eli Lilly and Company
    • 10.2.7. Pfizer Inc.
    • 10.2.8. Covance Inc.
    • 10.2.9. Novo Nordisk
    • 10.2.10. Rebus Bio

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Omics-Based Clinical Trials market, report scope
  • TABLE 2. Global Omics-Based Clinical Trials market estimates & forecasts by Region 2019-2028 (USD Billion)
  • TABLE 3. Global Omics-Based Clinical Trials market estimates & forecasts by Phase 2019-2028 (USD Billion)
  • TABLE 4. Global Omics-Based Clinical Trials market estimates & forecasts by Study Design 2019-2028 (USD Billion)
  • TABLE 5. Global Omics-Based Clinical Trials market estimates & forecasts by Indication 2019-2028 (USD Billion)
  • TABLE 6. Global Omics-Based Clinical Trials market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 7. Global Omics-Based Clinical Trials market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 8. Global Omics-Based Clinical Trials market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 9. Global Omics-Based Clinical Trials market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 10. Global Omics-Based Clinical Trials market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 11. Global Omics-Based Clinical Trials market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 12. Global Omics-Based Clinical Trials market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 13. Global Omics-Based Clinical Trials market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 14. Global Omics-Based Clinical Trials market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 15. Global Omics-Based Clinical Trials market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 16. U.S. Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 17. U.S. Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 18. U.S. Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 19. Canada Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 20. Canada Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 21. Canada Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 22. UK Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 23. UK Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 24. UK Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 25. Germany Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 26. Germany Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 27. Germany Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 28. RoE Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 29. RoE Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 30. RoE Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 31. China Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 32. China Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 33. China Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 34. India Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 35. India Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 36. India Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 37. Japan Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 38. Japan Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 39. Japan Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 40. RoAPAC Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 41. RoAPAC Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 42. RoAPAC Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 43. Brazil Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 44. Brazil Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 45. Brazil Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 46. Mexico Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 47. Mexico Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 48. Mexico Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 49. RoLA Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 50. RoLA Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 51. RoLA Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 52. Row Omics-Based Clinical Trials market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 53. Row Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 54. Row Omics-Based Clinical Trials market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 55. List of secondary sources, used in the study of global Omics-Based Clinical Trials market
  • TABLE 56. List of primary sources, used in the study of global Omics-Based Clinical Trials market
  • TABLE 57. Years considered for the study
  • TABLE 58. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Omics-Based Clinical Trials market, research methodology
  • FIG 2. Global Omics-Based Clinical Trials market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Omics-Based Clinical Trials market, key trends 2021
  • FIG 5. Global Omics-Based Clinical Trials market, growth prospects 2022-2028
  • FIG 6. Global Omics-Based Clinical Trials market, porters 5 force model
  • FIG 7. Global Omics-Based Clinical Trials market, pest analysis
  • FIG 8. Global Omics-Based Clinical Trials market, value chain analysis
  • FIG 9. Global Omics-Based Clinical Trials market by segment, 2019-2028(USD Billion)
  • FIG 10. Global Omics-Based Clinical Trials market by segment, 2019-2028(USD Billion)
  • FIG 11. Global Omics-Based Clinical Trials market by segment, 2019-2028(USD Billion)
  • FIG 12. Global Omics-Based Clinical Trials market by segment, 2019-2028(USD Billion)
  • FIG 13. Global Omics-Based Clinical Trials market by segment, 2019-2028(USD Billion)
  • FIG 14. Global Omics-Based Clinical Trials market, regional snapshot 2019 & 2028
  • FIG 15. North America Omics-Based Clinical Trials market 2019-2028(USD Billion)
  • FIG 16. Europe Omics-Based Clinical Trials market 2019-2028(USD Billion)
  • FIG 17. Asia pacific Omics-Based Clinical Trials market 2019-2028(USD Billion)
  • FIG 18. Latin America Omics-Based Clinical Trials market 2019-2028(USD Billion)
  • FIG 19. Global Omics-Based Clinical Trials market, company market share analysis (2021)